Ardelyx (ARDX) Non Operating Income (2014 - 2026)

Ardelyx (ARDX) reported Non Operating Income of $2.1 million for Q1 2026, down 9.2% on a YoY basis from $2.3 million in Q1 2025, and up 1.64% quarter-over-quarter from $2.1 million in Q4 2025.

Ardelyx (ARDX) Non Operating Income (2014 - 2026) Analysis & Trends

Ardelyx has reported Non Operating Income for 13 years, with the latest figure at $2.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 9.2% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (down 6.88% YoY), and the FY2025 full-year result was $8.7 million, down 4.68% from the prior year.
  • Non Operating Income for Q1 2026 stood at $2.1 million, up from $2.1 million in the prior quarter.
  • The five-year high for Non Operating Income was $2.4 million in Q3 2025, with the low at $70000.0 in Q2 2022.
  • Historically, Non Operating Income has averaged $1.7 million across 5 years, with a median of $2.1 million in 2025.
  • Annual changes were most pronounced in 2022 — Non Operating Income plunged 91.74% — and 2023, when it surged 2108.57%.
  • Ardelyx's Non Operating Income stood at $375000.0 in 2022, then jumped by 519.2% to $2.3 million in 2023, then advanced by 3.7% to $2.4 million in 2024, then decreased by 13.7% to $2.1 million in 2025, then increased by 1.64% to $2.1 million in 2026.
  • The last three Non Operating Income figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 2.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.11 Mn
Dec 31, 2025 2.08 Mn
Sep 30, 2025 2.45 Mn
Jun 30, 2025 1.89 Mn
Mar 31, 2025 2.33 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.28 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 2.34 Mn
Dec 31, 2023 2.32 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 375,000.00
Sep 30, 2022 704,000.00
Jun 30, 2022 70,000.00
Mar 31, 2022 484,000.00
Dec 31, 2021 23,000.00
Sep 30, 2021 -134,000.00
Jun 30, 2021 847,000.00